跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
TAPENTADOL TEVA 25 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
TAPENTADOL TEVA 25 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2022
Approval ID
1955eea607bd9187
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
1955eea607bd9187
Drug Cima Aemps Name
TAPENTADOL TEVA 25 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
88376
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2022-12-09
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
Yes
Company Name
Teva Pharma S.L.U.
Active Ingredients
TAPENTADOL FOSFATO
38,28 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2022
Approval ID
1955eea607bd9187
Type
Standard
Back to CIMA-AEMPS Approvals
TAPENTADOL TEVA 25 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details